BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12085968)

  • 1. Angiogenesis in prostate cancer: biology and therapeutic opportunities.
    Nicholson B; Schaefer G; Theodorescu D
    Cancer Metastasis Rev; 2001; 20(3-4):297-319. PubMed ID: 12085968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenesis and prostate cancer tumor growth.
    Nicholson B; Theodorescu D
    J Cell Biochem; 2004 Jan; 91(1):125-50. PubMed ID: 14689586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pathophysiological mechanisms of angiogenesis in atherogenesis].
    Vucević D; Radak D; Milovanović I; Radosavljević T; Mladenović D
    Med Pregl; 2013; 66(7-8):297-306. PubMed ID: 24069811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiogenic potential of prostate carcinoma cells overexpressing bcl-2.
    Fernandez A; Udagawa T; Schwesinger C; Beecken W; Achilles-Gerte E; McDonnell T; D'Amato R
    J Natl Cancer Inst; 2001 Feb; 93(3):208-13. PubMed ID: 11158189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting vasculature in urologic tumors: mechanistic and therapeutic significance.
    Sakamoto S; Ryan AJ; Kyprianou N
    J Cell Biochem; 2008 Feb; 103(3):691-708. PubMed ID: 17668426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenesis of prostate cancer and antiangiogenic therapy.
    Uehara H
    J Med Invest; 2003 Aug; 50(3-4):146-53. PubMed ID: 13678383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiogenesis inhibitors in the treatment of prostate cancer.
    Adesunloye BA; Karzai FH; Dahut WL
    Chem Immunol Allergy; 2014; 99():197-215. PubMed ID: 24217611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiangiogenesis therapeutic strategies in prostate cancer.
    Macpherson GR; Ng SS; Lakhani NJ; Price DK; Venitz J; Figg WD
    Cancer Metastasis Rev; 2002; 21(1):93-106. PubMed ID: 12400998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostatic angiogenic responses in late life: antiangiogenic therapy influences and relation with the glandular microenvironment in the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
    Montico F; Kido LA; Hetzl AC; Cagnon VH
    Prostate; 2015 Apr; 75(5):484-99. PubMed ID: 25521760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenesis in prostate cancer: its role in disease progression and possible therapeutic approaches.
    van Moorselaar RJ; Voest EE
    Mol Cell Endocrinol; 2002 Nov; 197(1-2):239-50. PubMed ID: 12431818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
    Gacche RN; Meshram RJ
    Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEGF as a key mediator of angiogenesis in cancer.
    Carmeliet P
    Oncology; 2005; 69 Suppl 3():4-10. PubMed ID: 16301830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenic and anti-angiogenic factors in adrenal tumours.
    Jurczyńska J; Zieleniewski W; Stepień H; Komorowski J
    Endokrynol Pol; 2006; 57(6):633-40. PubMed ID: 17253437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neoplasms and angiogenesis].
    Lewy-Trenda I
    Pol Merkur Lekarski; 2002 Sep; 13(75):225-8. PubMed ID: 12474576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiangiogenic treatment with linomide as chemoprevention for prostate, seminal vesicle, and breast carcinogenesis in rodents.
    Joseph IB; Vukanovic J; Isaacs JT
    Cancer Res; 1996 Aug; 56(15):3404-8. PubMed ID: 8758902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Angiogenesis and antiangiogenic cancer therapy].
    Pour L; Hájek R; Buchler T; Maisnar V; Smolej L
    Vnitr Lek; 2004 Dec; 50(12):930-8. PubMed ID: 15717808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenesis as a potential biomarker in prostate cancer chemoprevention trials.
    Ali IU; Senger DR; Smith LE
    Urology; 2001 Apr; 57(4 Suppl 1):143-7. PubMed ID: 11295614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiostatic and angiogenic factors.
    de Groot H; Schmit-Eilenberger V; Kirchhof J; Augustin AJ
    Dev Ophthalmol; 2010; 46():1-3. PubMed ID: 20703028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous inhibitors of angiogenesis.
    Nyberg P; Xie L; Kalluri R
    Cancer Res; 2005 May; 65(10):3967-79. PubMed ID: 15899784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenesis and its therapeutic opportunities.
    Yoo SY; Kwon SM
    Mediators Inflamm; 2013; 2013():127170. PubMed ID: 23983401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.